One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v118.21.3711.3711
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 18, 2011 |
 Citations: 9 |
Affiliation: University of Alabama at Birmingham, Baylor University Medical Center, Stanford Medicine, Washington University in St. Louis, City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, New York University Langone Medical Center, Nationwide Children's Hospital, Loyola University Chicago, Seagen (United States), Colorado Blood Cancer Institute
Prolonged Treatment with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL),
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
